Chartwell Partners is honored to have been selected to partner with Taysha Gene Therapies on appointing new Board members: Kathy Reape, M.D., former Chief Medical Officer of Spark Therapeutics, and Laura Sepp-Lorenzino, Ph.D., Chief Scientific Officer of Intellia Therapeutics. Both women bring broad pharmaceutical industry experience and tremendous gene therapy expertise to Taysha, from leading…
Archives
- March 2024
- February 2024
- October 2023
- July 2023
- June 2023
- May 2023
- April 2023
- January 2023
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- June 2021
- April 2021
- March 2021
- February 2021
- January 2021
- November 2020
- September 2020
- August 2020
- July 2020
- June 2020
- April 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- March 2019
- December 2018
- August 2018
- June 2018
- May 2018
- April 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- July 2017
- May 2017
- April 2017
- February 2017
- January 2017
- December 2016
- November 2016
- September 2016
- April 2016
- July 2015
- January 2015
- August 2014